Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease

Francesca Gelfo, Paola Tirassa, Paola De Bartolo, Carlo Caltagirone, Laura Petrosini, Francesco Angelucci

Research output: Contribution to journalArticle

Abstract

Different Alzheimer's disease (AD) stages may be characterized by different directions in nerve growth factor (NGF) changes, suggesting that NGF may serve as peripheral marker of AD. To characterize the time course of NGF changes in an AD animal model, we measured NGF brain and serum levels at 3, 7, and 15 days from cholinergic depletion. NGF levels increased in the frontal cortex and hippocampus at 3 and 7 days and decreased in the serum at 7 days from lesion, suggesting that opposite changes in brain and serum occur at early stages of cholinergic depletion. When compared to human data, these findings further elucidate the role of NGF in early and late AD disease stages.

Original languageEnglish
Pages (from-to)213-217
Number of pages5
JournalJournal of Alzheimer's Disease
Volume25
Issue number2
DOIs
Publication statusPublished - 2011

Fingerprint

Nerve Growth Factor
Alzheimer Disease
Brain
Serum
Cholinergic Agents
Frontal Lobe
Hippocampus
Animal Models

Keywords

  • ChAT
  • cholinergic neurons
  • neurotrophins
  • Saporin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease. / Gelfo, Francesca; Tirassa, Paola; De Bartolo, Paola; Caltagirone, Carlo; Petrosini, Laura; Angelucci, Francesco.

In: Journal of Alzheimer's Disease, Vol. 25, No. 2, 2011, p. 213-217.

Research output: Contribution to journalArticle

@article{eb654b0b3e6c41d09894027e6b15108e,
title = "Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease",
abstract = "Different Alzheimer's disease (AD) stages may be characterized by different directions in nerve growth factor (NGF) changes, suggesting that NGF may serve as peripheral marker of AD. To characterize the time course of NGF changes in an AD animal model, we measured NGF brain and serum levels at 3, 7, and 15 days from cholinergic depletion. NGF levels increased in the frontal cortex and hippocampus at 3 and 7 days and decreased in the serum at 7 days from lesion, suggesting that opposite changes in brain and serum occur at early stages of cholinergic depletion. When compared to human data, these findings further elucidate the role of NGF in early and late AD disease stages.",
keywords = "ChAT, cholinergic neurons, neurotrophins, Saporin",
author = "Francesca Gelfo and Paola Tirassa and {De Bartolo}, Paola and Carlo Caltagirone and Laura Petrosini and Francesco Angelucci",
year = "2011",
doi = "10.3233/JAD-2011-110047",
language = "English",
volume = "25",
pages = "213--217",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease

AU - Gelfo, Francesca

AU - Tirassa, Paola

AU - De Bartolo, Paola

AU - Caltagirone, Carlo

AU - Petrosini, Laura

AU - Angelucci, Francesco

PY - 2011

Y1 - 2011

N2 - Different Alzheimer's disease (AD) stages may be characterized by different directions in nerve growth factor (NGF) changes, suggesting that NGF may serve as peripheral marker of AD. To characterize the time course of NGF changes in an AD animal model, we measured NGF brain and serum levels at 3, 7, and 15 days from cholinergic depletion. NGF levels increased in the frontal cortex and hippocampus at 3 and 7 days and decreased in the serum at 7 days from lesion, suggesting that opposite changes in brain and serum occur at early stages of cholinergic depletion. When compared to human data, these findings further elucidate the role of NGF in early and late AD disease stages.

AB - Different Alzheimer's disease (AD) stages may be characterized by different directions in nerve growth factor (NGF) changes, suggesting that NGF may serve as peripheral marker of AD. To characterize the time course of NGF changes in an AD animal model, we measured NGF brain and serum levels at 3, 7, and 15 days from cholinergic depletion. NGF levels increased in the frontal cortex and hippocampus at 3 and 7 days and decreased in the serum at 7 days from lesion, suggesting that opposite changes in brain and serum occur at early stages of cholinergic depletion. When compared to human data, these findings further elucidate the role of NGF in early and late AD disease stages.

KW - ChAT

KW - cholinergic neurons

KW - neurotrophins

KW - Saporin

UR - http://www.scopus.com/inward/record.url?scp=79960158727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960158727&partnerID=8YFLogxK

U2 - 10.3233/JAD-2011-110047

DO - 10.3233/JAD-2011-110047

M3 - Article

C2 - 21368378

AN - SCOPUS:79960158727

VL - 25

SP - 213

EP - 217

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -